Literature DB >> 2684596

Hypertension in the diabetic patient. Selection and optimum use of antihypertensive drugs.

B N Trost1.   

Abstract

Understanding of the pathophysiology of hypertension and diabetes mellitus and their association is at present fragmentary at best. Optimal antihypertensive drug therapy of patients with both disorders is therefore based on limited experimental data, practical experience and educated guesswork, and needs to be tailored to each (often multimorbid) individual. In most patients monotherapy would be preferred, and would begin with a calcium antagonist or a converting enzyme inhibitor at a low to moderate dosage. If this is not effective an alpha 1-adrenoceptor inhibitor, a cardioselective beta-blocker or a diuretic, always at a low to moderate dosage, should be tried. If still unsuccessful, low dose combinations of 2 of these drugs are next. The (long term) regimen should be as simple as possible, and its effects--desired and undesired--monitored as closely as the carbohydrate disorder.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684596     DOI: 10.2165/00003495-198938040-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  83 in total

1.  Indoramin in the hypertensive diabetic patient.

Authors:  V P Sood; M Stannard; G Beastall; R J Weir
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

Review 2.  Medical intelligence drug therapy: captopril.

Authors:  D G Vidt; E L Bravo; F M Fouad
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245

3.  [Effect of antihypertensive drug combination therapy on the metabolism in diabetics].

Authors:  H U Janka; R Standl; J Vollmar; G Bauer; H Mehnert
Journal:  Ther Ggw       Date:  1980-01

4.  Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus.

Authors:  J R Dominguez; H de la Calle; A Hurtado; R G Robles; J Sancho-Rof
Journal:  Postgrad Med J       Date:  1986       Impact factor: 2.401

5.  [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].

Authors:  U Hay; B Ludvik; C Gisinger; G Schernthaner
Journal:  Schweiz Med Wochenschr       Date:  1988-02-06

6.  Hypotensive effect of the association atenolol-chlorthalidone in hypertensive diabetics.

Authors:  S Gentile; M Coltorti
Journal:  J Int Med Res       Date:  1984       Impact factor: 1.671

7.  Timolol treatment after myocardial infarction in diabetic patients.

Authors:  T Gundersen; J Kjekshus
Journal:  Diabetes Care       Date:  1983 May-Jun       Impact factor: 19.112

8.  Treatment of systemic hypertension in insulin-treated diabetes mellitus with rilmenidine.

Authors:  M Mpoy; B Vandeleene; J M Ketelslegers; A E Lambert
Journal:  Am J Cardiol       Date:  1988-02-24       Impact factor: 2.778

9.  Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

Authors:  A H Barnett; D Leslie; P J Watkins
Journal:  Br Med J       Date:  1980-04-05

10.  Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine one year.

Authors:  J H Hauger-Klevene; J C Scornavacchi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  2 in total

Review 1.  Treatment of lower extremity infections in diabetics.

Authors:  W S Joseph
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 2.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.